Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epigenomic regulation of neural crest differentiation in human-induced pluripotent stem cells.

iScience·2026
Same author

Imbalance Between CD44 and STAT3 Enhances Spheroid Viability and Impairs Pembrolizumab Response in Urothelial Cancer.

Anticancer research·2026
Same author

Telomere maintenance mechanisms are activated in ganglioneuroblastoma and ganglioneuroma.

Oncology letters·2026
Same author

Coexpression of MYCN and ALK Induces Neuroblastoma-Like Tumors From Human iPS Cell-Derived Cranial Neural Crest Cells.

Genes to cells : devoted to molecular & cellular mechanisms·2026
Same author

Improved Outcomes for Older Children, Adolescents, and Young Adults With Neuroblastoma in the Post-Immunotherapy Era: An Updated Report From the International Neuroblastoma Risk Group.

Pediatric blood & cancer·2026
Same author

Synthetic lethality of EZH2 and DNMT Inhibition suppresses neuroblastoma proliferation via MYCN destabilization.

BMC cancer·2025

Related Experiment Video

Updated: Aug 16, 2025

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

183

Comparative epigenomics by machine learning approach for neuroblastoma.

Ryuichi P Sugino1, Miki Ohira1, Sayaka P Mansai1

  • 1Research Institute for Clinical Oncology, Saitama Cancer Center, Ina, Saitama, 362-0806, Japan.

BMC Genomics
|December 26, 2022
PubMed
Summary

Random forest analysis identified novel intermediate-risk neuroblastoma patient groups. This machine learning approach aids in understanding DNA methylation patterns and discovering new cancer-related genes for improved prognosis.

Keywords:
Comparative epigenomicsDNA methylationMachine learningNeuroblastoma

More Related Videos

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.2K
Pattern-based Search of Epigenomic Data Using GeNemo
06:38

Pattern-based Search of Epigenomic Data Using GeNemo

Published on: October 8, 2017

5.2K

Related Experiment Videos

Last Updated: Aug 16, 2025

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

183
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.2K
Pattern-based Search of Epigenomic Data Using GeNemo
06:38

Pattern-based Search of Epigenomic Data Using GeNemo

Published on: October 8, 2017

5.2K

Area of Science:

  • Oncology
  • Epigenetics
  • Bioinformatics

Background:

  • Neuroblastoma (NB) is a common pediatric solid tumor where epigenetic factors, specifically DNA methylation, are crucial for progression.
  • Limited analytical models hinder the study of DNA methylation variations in NB prognosis.
  • Understanding DNA methylation's role is vital for improving neuroblastoma treatment outcomes.

Purpose of the Study:

  • To apply random forest (RF) analysis to neuroblastoma DNA methylome data for identifying novel prognostic markers.
  • To develop an analytical model for understanding DNA methylation patterns in neuroblastoma.
  • To discover candidate genes associated with neuroblastoma progression.

Main Methods:

  • Utilized random forest (RF) machine learning for analyzing DNA methylome data from multiple neuroblastoma databases.
  • Performed feature selection based on probe annotation to identify predictive regions, particularly enhancers.
  • Developed a gene-based analytical model to pinpoint genes linked to disease progression.

Main Results:

  • RF analysis successfully identified novel intermediate-risk neuroblastoma patient subgroups with distinct DNA methylation profiles.
  • Enhancer-annotated regions demonstrated significant predictive power, especially in MYCN-amplified neuroblastomas.
  • Candidate genes, including PRDM8 and FAM13A-AS1, were identified as potentially related to neuroblastoma progression.
  • RF models exhibited strong predictive accuracy compared to other machine learning approaches.

Conclusions:

  • Random forest (RF) is an effective tool for analyzing DNA methylome data in cancer epigenetics.
  • This approach can identify novel cancer-related genes and refine risk stratification in neuroblastoma.
  • RF analysis holds promise for advancing our understanding of neuroblastoma epigenetics and developing targeted therapies.